Dr. Daniel A Wolde Rufael is an Infectious Disease Specialist and provides outpatient care and consults for patients infected with HIV disease, Hepatitis B and Hepatitis C. Dr. Wolde Rufael treats HIV infected patients who have extensive experience with antiretroviral treatment and need new regime to control HIV disease; HIV patients with metabolic complications, HIV patients coinfected with Hepatitis B and Hepatitis C. He also provides Inpatient care and infectious disease consult for HIV patients.
Dr. Wolde Rufael participates in clinical trial research to study HIV and Hepatitis C treatment at the Institute of Human Virology located at the University of Maryland and is interested in clinical studies to determine optimal salvage antiretroviral regimens.
Peer Reviewed Journals
Wolde-Rufael DA., Cohn S. Corynebacterium Endocarditis Case Reports and a Review of the Literature. Clinical Infectious Disease, 1994; Vol. 19(6); 1054-61.
Wolde-Rufael D., Campo R., DiCapraris PJ, Jefferson R., Stansell J., Butcher D., Urdaneta M., Guong P. and Markson L., How well are we doing in Adopting HIV Treatment Guidelines, Abstract #104, 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, January 31 – February 4, 1999.